Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection

https://doi.org/10.1016/S0002-9149(02)02525-0Get rights and content

Abstract

Systolic and diastolic myocardial performance characteristics are altered during allograft rejection. Noninvasive diagnostic markers of allograft rejection have thus far not been found to be clinically useful and have not replaced routine endomyocardial biopsy as a method to detect rejection. We examined the clinical utility of the Index of Myocardial Performance (IMP), or the Tei index, a combined index of systolic and diastolic performance (derived as a composite ratio of isovolumetric contraction time and isovolumetric relaxation time to the ejection time), in evaluating and following cardiac allograft rejection. Twenty heart transplant recipients with moderate cellular rejection (International Society for Heart and Lung Transplantation [ISHLT] grade 3A) underwent echocardiographic assessment to derive the IMP at baseline (rejection free), during treatment of rejection, and after recovery from rejection (group I). A parallel group of 20 nonrejecters (ISHLT grade 1A) were also similarly examined to serve as controls (group II). In group I patients, there was a mean increase of IMP by 98% (p <0.0001) during the rejection episode compared with baseline. After treatment, IMP decreased to its baseline value. In the control group there was no significant change in IMP over time. An IMP increase of ≥20% from baseline had 90% sensitivity and 90% specificity in detecting high-grade cardiac allograft rejection. The change in IMP in patients with grade 3A cellular rejection was independent of both the ejection fraction at baseline and change in ejection fraction during the rejection episode. These results indicate that changes in IMP, a sensitive marker of early diastolic and systolic performance, accurately evaluate the development of, and recovery from, cardiac allograft rejection. IMP can provide a clinically useful noninvasive indicator to assess the impact of therapy for amelioration of allograft rejection.

Section snippets

Study patients

The study consisted of 40 patients (28 men and 12 women) who survived orthotopic heart transplantation between 1996 and 1999 at the Ochsner Heart and Vascular Institute in New Orleans, Louisiana. All patients underwent serial echocardiographic examination within 2 hours before endomyocardial biopsy. The biopsy samples, after histopathologic analysis, were graded per standard ISHLT grading.10 The biopsy grade and echocardiographic indexes were analyzed in a blinded fashion.

M-mode, 2-dimensional, and doppler echocardiography

Echocardiographic

Patient characteristics

The baseline patient characteristics are listed in Table 1. There was no significant difference between the 2 groups with regard to age, sex, systemic hypertension, diabetes, and immunosuppressive regimen.

Correlation of the change in IMP with cardiac allograft rejection

On serial assessment of the change of IMP in group I patients (Figure 2), there was a statistically significant 98% increase of IMP during high-grade cellular rejection (0.42 ± 0.18 to 0.83 ± 0.33; p <0.0001). In contrast, IMP in group II patients (Figure 2) had no significant change over

Discussion

Cardiac allograft rejection affects systolic and diastolic myocardial performance.11 A new Doppler index, combining systolic and diastolic time intervals as an expression of global myocardial performance, has been shown to be of prognostic value in patients with dilated cardiomyopathy and infiltrative heart diseases (e.g., cardiac amyloidosis).8, 9 Our study has shown that this index is very helpful in identifying high-grade cellular cardiac allograft rejection. It should be emphasized that the

References (12)

There are more references available in the full text version of this article.

Cited by (0)

View full text